Tracie‐Ann Madden

Elevated Levels of Epidermal Growth Factor Receptor/c-erbB2 Heterodimers Mediate an Autocrine Growth Regulatory Pathway in Tamoxifen-Resistant MCF-7 Cells

Janice M. Knowlden, Iain R. Hutcheson, Helen E. Jones et al. · Endocrinology · 2003 · 534 citations · Full text

Medicine, Cell Biology, Oncology +17

Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomised controlled trial

Christopher Butler, Richard Hobbs, Oghenekome Gbinigie et al. · The Lancet · 2022 · 406 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +7

Enhanced Epidermal Growth Factor Receptor Signaling in MCF7 Breast Cancer Cells after Long-Term Culture in the Presence of the Pure Antiestrogen ICI 182,780 (Faslodex)*

Richard A. McClelland, Denise Barrow, Tracie‐Ann Madden et al. · Endocrinology · 2001 · 249 citations · Full text

Life Sciences, Cancer Biology, Oncology +17

Fulvestrant plus capivasertib versus placebo after relapse or progression on an aromatase inhibitor in metastatic, oestrogen receptor-positive breast cancer (FAKTION): a multicentre, randomised, controlled, phase 2 trial

Robert H. Jones, Angela Casbard, Margherita Carucci et al. · The Lancet Oncology · 2020 · 227 citations · Full text

Medicine, Oncology, Pharmacology +17

Oestrogen Receptor-Mediated Modulation of the EGFR/MAPK Pathway in Tamoxifen-Resistant MCF-7 Cells

Iain R. Hutcheson, Janice M. Knowlden, Tracie‐Ann Madden et al. · Breast Cancer Research and Treatment · 2003 · 173 citations

Life Sciences, Cell Biology, Oncology +15